Necroptosis, in vivo detection in experimental disease models

Seminars in Cell and Developmental Biology

Volumn 35, Issue , 2014, Pages 2-13

  Jouan Lanhouet, Sandrine ^a,b   Riquet, Franck ^b,c   Duprez, Linde ^a,b   Vanden Berghe, Tom ^a,b   Takahashi, Nozomi ^a,b   Vandenabeele, Peter ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIV LILLE   (France)

Author keywords

Experimental disease models; Methods; MLKL; Necroptosis; RIPK1 3

Indexed keywords

BIOLOGICAL MARKER; MIXED LINEAGE KINASE; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 1; RECEPTOR INTERACTING PROTEIN KINASE 3; UNCLASSIFIED DRUG; CASPASE 8; MLKL PROTEIN, HUMAN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK1 PROTEIN, HUMAN; RIPK3 PROTEIN, HUMAN;

ACUTE HEPATITIS; ACUTE KIDNEY FAILURE; ACUTE PANCREATITIS; BACTERIAL INFECTION; CELL SURVIVAL; CHRONIC LIVER DISEASE; DEGENERATIVE DISEASE; DERMATITIS; ENZYME PHOSPHORYLATION; EXPERIMENTAL DERMATITIS; EXPERIMENTAL DISEASE; EXPERIMENTAL EYE DISEASE; EXPERIMENTAL INFECTION; EXPERIMENTAL NEUROLOGIC DISEASE; EXPERIMENTAL PANCREATITIS; EXPERIMENTAL SPINAL CORD INJURY; EXPERIMENTAL STROKE; EXPERIMENTAL UROGENITAL DISEASE; HUMAN; IN VIVO STUDY; INFLAMMATORY BOWEL DISEASE; NECROPTOSIS; NONHUMAN; PARASITOSIS; REPERFUSION INJURY; RETINA DISEASE; REVIEW; SEPSIS; TRANSGENIC ANIMAL; TRAUMATIC BRAIN INJURY; VIRUS INFECTION; ANIMAL; BIOLOGICAL MODEL; METABOLISM; NECROSIS; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION;

ANIMALS; CASPASE 8; HUMANS; MODELS, BIOLOGICAL; NECROSIS; PATHOLOGY, CLINICAL; PROTEIN KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 84908703873     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.08.010     Document Type: Review

References (174)

1. Ziegler U., Groscurth P. Morphological features of cell death. News Physiol Sci 2004, 19:124-128.
2. Virchow R. Lecture XV. Passive processes, fatty degeneration. Cellular pathology as based upon physiological and pathological histology [translated in English by Chance F, Cantab MB], vol. 1860. p. 318.
3. Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012, 19:107-120.
4. Sun L., Wang H., Wang Z., He S., Chen S., Liao D., et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012, 148:213-227.
5. Vanden Berghe T., Linkermann A., Jouan-Lanhouet S., Walczak H., Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014, 15:135-147.
6. Galluzzi L., Vanden Berghe T., Vanlangenakker N., Buettner S., Eisenberg T., Vandenabeele P., et al. Programmed necrosis from molecules to health and disease. Int Rev Cell Mol Biol 2011, 289:1-35.
7. Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010, 11:700-714.
8. Vanden Berghe T., Vanlangenakker N., Parthoens E., Deckers W., Devos M., Festjens N., et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ 2010, 17:922-930.
9. Newton K., Sun X., Dixit V.M. Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol 2004, 24:1464-1469.
10. Linkermann A., Green D.R. Necroptosis. N Engl J Med 2014, 370:455-465.
11. Kaiser W.J., Upton J.W., Long A.B., Livingston-Rosanoff D., Daley-Bauer L.P., Hakem R., et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011, 471:368-372.
12. Oberst A., Dillon C.P., Weinlich R., McCormick L.L., Fitzgerald P., Pop C., et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011, 471:363-367.
13. Zhang H., Zhou X., McQuade T., Li J., Chan F.K., Zhang J. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 2011, 471:373-376.
14. Kaiser W.J., Daley-Bauer L.P., Thapa R.J., Mandal P., Berger S.B., Huang C., et al. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc Natl Acad Sci USA 2014, 111:7753-7758.
15. Polykratis A., Hermance N., Zelic M., Roderick J., Kim C., Van T.M., et al. Cutting edge: RIPK1 kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J Immunol 2014, 193:1539-1543.
16. Rickard J.A., O'Donnell J.A., Evans J.M., Lalaoui N., Poh A.R., Rogers T., et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 2014, 157:1175-1188.
17. Dillon C.P., Weinlich R., Rodriguez D.A., Cripps J.G., Quarato G., Gurung P., et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 2014, 157:1189-1202.
18. Zitvogel L., Kepp O., Kroemer G. Decoding cell death signals in inflammation and immunity. Cell 2010, 140:798-804.
19. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010, 10:826-837.
20. Kaczmarek A., Vandenabeele P., Krysko D.V. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013, 38:209-223.
21. Krysko D.V., Agostinis P., Krysko O., Garg A.D., Bachert C., Lambrecht B.N., et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011, 32:157-164.
22. Smith C.C., Yellon D.M. Necroptosis, necrostatins and tissue injury. J Cell Mol Med 2011, 15:1797-1806.
23. Moriwaki K., Chan F.K. RIP3: a molecular switch for necrosis and inflammation. Genes Dev 2013, 27:1640-1649.
24. Moriwaki K., Chan F.K. Necrosis-dependent and independent signaling of the RIP kinases in inflammation. Cytokine Growth Factor Rev 2014, 25:167-174.
25. Vanlangenakker N., Vanden Berghe T., Vandenabeele P. Many stimuli pull the necrotic trigger, an overview. Cell Death Differ 2012, 19:75-86.
26. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000, 1:489-495.
27. Wilson C.A., Browning J.L. Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ 2002, 9:1321-1333.
28. Ch'en I.L., Beisner D.R., Degterev A., Lynch C., Yuan J., Hoffmann A., et al. Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc Natl Acad Sci USA 2008, 105:17463-17468.
29. Thapa R.J., Nogusa S., Chen P., Maki J.L., Lerro A., Andrake M., et al. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci USA 2013, 110:E3109-E3118.
30. Han W., Li L., Qiu S., Lu Q., Pan Q., Gu Y., et al. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther 2007, 6:1641-1649.
31. Huang C., Luo Y., Zhao J., Yang F., Zhao H., Fan W., et al. Shikonin kills glioma cells through necroptosis mediated by RIP-1. PLoS ONE 2013, 8:e66326.
32. Basit F., Cristofanon S., Fulda S., Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. Cell Death Differ 2013, 20:1161-1173.
33. Kalai M., Van Loo G., Vanden Berghe T., Meeus A., Burm W., Saelens X., et al. Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA. Cell Death Differ 2002, 9:981-994.
34. Ma Y., Temkin V., Liu H., Pope R.M. NF-kappaB protects macrophages from lipopolysaccharide-induced cell death: the role of caspase 8 and receptor-interacting protein. J Biol Chem 2005, 280:41827-41834.
35. Kaiser W.J., Sridharan H., Huang C., Mandal P., Upton J.W., Gough P.J., et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem 2013, 288:31268-31279.
36. Feoktistova M., Geserick P., Kellert B., Dimitrova D.P., Langlais C., Hupe M., et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011, 43:449-463.
37. Tenev T., Bianchi K., Darding M., Broemer M., Langlais C., Wallberg F., et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011, 43:432-448.
38. Davis C.W., Hawkins B.J., Ramasamy S., Irrinki K.M., Cameron B.A., Islam K., et al. Nitration of the mitochondrial complex I subunit NDUFB8 elicits RIP1- and RIP3-mediated necrosis. Free Radic Biol Med 2010, 48:306-317.
39. Kim S., Dayani L., Rosenberg P.A., Li J. RIP1 kinase mediates arachidonic acid-induced oxidative death of oligodendrocyte precursors. Int J Physiol Pathophysiol Pharmacol 2010, 2:137-147.
40. Cho Y.S., Challa S., Moquin D., Genga R., Ray T.D., Guildford M., et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009, 137:1112-1123.
41. Upton J.W., Kaiser W.J., Mocarski E.S. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 2012, 11:290-297.
42. Bertrand M.J., Vandenabeele P. The Ripoptosome: death decision in the cytosol. Mol Cell 2011, 43:323-325.
43. He S., Wang L., Miao L., Wang T., Du F., Zhao L., et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137:1100-1111.
44. Zhang D.W., Shao J., Lin J., Zhang N., Lu B.J., Lin S.C., et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009, 325:332-336.
45. McQuade T., Cho Y., Chan F.K. Positive and negative phosphorylation regulates RIP1- and RIP3-induced programmed necrosis. Biochem J 2013, 456:409-415.
46. Li J., McQuade T., Siemer A.B., Napetschnig J., Moriwaki K., Hsiao Y.S., et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 2012, 150:339-350.
47. Wu X.N., Yang Z.H., Wang X.K., Zhang Y., Wan H., Song Y., et al. Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ 2014, [Epub ahead of print]. 10.1038/cdd.2014.77.
48. Orozco S., Yatim N., Werner M.R., Tran H., Gunja S.Y., Tait S.W., et al. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ 2014, [Epub ahead of print]. 10.1038/cdd.2014.76.
49. Zhao J., Jitkaew S., Cai Z., Choksi S., Li Q., Luo J., et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA 2012, 109:5322-5327.
50. Chen W., Zhou Z., Li L., Zhong C.Q., Zheng X., Wu X., et al. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J Biol Chem 2013, 288:16247-16261.
51. Murphy J.M., Czabotar P.E., Hildebrand J.M., Lucet I.S., Zhang J.G., Alvarez-Diaz S., et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013, 39:443-453.
52. Wang H., Sun L., Su L., Rizo J., Liu L., Wang L.F., et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 2014, 54:133-146.
53. Cai Z., Jitkaew S., Zhao J., Chiang H.C., Choksi S., Liu J., et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 2014, 16:55-65.
54. Chen X., Li W., Ren J., Huang D., He W.T., Song Y., et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res 2014, 24:105-121.
55. Dondelinger Y., Declercq W., Montessuit S., Roelandt R., Goncalves A., Bruggeman I., et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 2014, 7:971-981.
56. Vanlangenakker N., Vanden Berghe T., Bogaert P., Laukens B., Zobel K., Deshayes K., et al. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ 2011, 18:656-665.
57. Silke J., Strasser A. The FLIP side of life. Sci Signal 2013, 6:pe2.
58. Berger S.B., Kasparcova V., Hoffman S., Swift B., Dare L., Schaeffer M., et al. Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J Immunol 2014, 192:5476-5480.
59. Newton K., Dugger D.L., Wickliffe K.E., Kapoor N., de Almagro M.C., Vucic D., et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 2014, 343:1357-1360.
60. Dondelinger Y., Aguileta M.A., Goossens V., Dubuisson C., Grootjans S., Dejardin E., et al. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ 2013, 20:1381-1392.
61. Moquin D.M., McQuade T., Chan F.K. CYLD deubiquitinates RIP1 in the TNFalpha-induced necrosome to facilitate kinase activation and programmed necrosis. PLoS ONE 2013, 8:e76841.
62. Narayan N., Lee I.H., Borenstein R., Sun J., Wong R., Tong G., et al. The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature 2012, 492:199-204.
63. Cook W.D., Moujalled D.M., Ralph T.J., Lock P., Young S.N., Murphy J.M., et al. RIPK1- and RIPK3-induced cell death mode is determined by target availability. Cell Death Differ 2014, [Epub ahead of print]. 10.1038/cdd.2014.70.
64. Newton K., Hildebrand J.M., Shen Z., Rodriguez D., Alvarez-Diaz S., Petersen S., et al. Is SIRT2 required for necroptosis. Nature 2014, 506:E4-E6.
65. Upton J.W., Kaiser W.J., Mocarski E.S. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 2010, 7:302-313.
66. Meylan E., Burns K., Hofmann K., Blancheteau V., Martinon F., Kelliher M., et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 2004, 5:503-507.
67. He S., Liang Y., Shao F., Wang X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci USA 2011, 108:20054-20059.
68. Kelliher M.A., Grimm S., Ishida Y., Kuo F., Stanger B.Z., Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 1998, 8:297-303.
69. Wong W.W., Gentle I.E., Nachbur U., Anderton H., Vaux D.L., Silke J. RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. Cell Death Differ 2010, 17:482-487.
70. Christofferson D.E., Li Y., Hitomi J., Zhou W., Upperman C., Zhu H., et al. A novel role for RIP1 kinase in mediating TNFalpha production. Cell Death Dis 2012, 3:e320.
71. Wong W.W., Vince J.E., Lalaoui N., Lawlor K.E., Chau D., Bankovacki A., et al. cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner. Blood 2014, 123:2562-2572.
72. Vince J.E., Wong W.W., Gentle I., Lawlor K.E., Allam R., O'Reilly L., et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 2012, 36:215-227.
73. Kang T.B., Yang S.H., Toth B., Kovalenko A., Wallach D. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 2013, 38:27-40.
74. Khan N., Lawlor K.E., Murphy J.M., Vince J.E. More to life than death: molecular determinants of necroptotic and non-necroptotic RIP3 kinase signaling. Curr Opin Immunol 2014, 26:76-89.
75. Kang T.B., Yang S.H., Toth B., Kovalenko A., Wallach D. Activation of the NLRP3 inflammasome by proteins that signal for necroptosis. Methods Enzymol 2014, 545:67-81.
76. Wang L., Du F., Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 2008, 133:693-703.
77. Geserick P., Hupe M., Moulin M., Wong W.W., Feoktistova M., Kellert B., et al. Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol 2009, 187:1037-1054.
78. Petersen S.L., Wang L., Yalcin-Chin A., Li L., Peyton M., Minna J., et al. Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 2007, 12:445-456.
79. Vanden Berghe T., Grootjans S., Goossens V., Dondelinger Y., Krysko D.V., Takahashi N., et al. Determination of apoptotic and necrotic cell death in vitro and in vivo. Methods 2013, 61:117-129.
80. Oerlemans M.I., Liu J., Arslan F., den Ouden K., van Middelaar B.J., Doevendans P.A., et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Res Cardiol 2012, 107:270.
81. Sato K., Li S., Gordon W.C., He J., Liou G.I., Hill J.M., et al. Receptor interacting protein kinase-mediated necrosis contributes to cone and rod photoreceptor degeneration in the retina lacking interphotoreceptor retinoid-binding protein. J Neurosci 2013, 33:17458-17468.
82. Viringipurampeer I.A., Shan X., Gregory-Evans K., Zhang J.P., Mohammadi Z., Gregory-Evans C.Y. Rip3 knockdown rescues photoreceptor cell death in blind pde6c zebrafish. Cell Death Differ 2014, 21:665-675.
83. Csak T., Dolganiuc A., Kodys K., Nath B., Petrasek J., Bala S., et al. Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice. Hepatology 2011, 53:1917-1931.
84. Gandhirajan R.K., Meng S., Chandramoorthy H.C., Mallilankaraman K., Mancarella S., Gao H., et al. Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammation. J Clin Invest 2013, 123:887-902.
85. Gunther C., Martini E., Wittkopf N., Amann K., Weigmann B., Neumann H., et al. Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 2011, 477:335-339.
86. Dong K., Zhu H., Song Z., Gong Y., Wang F., Wang W., et al. Necrostatin-1 protects photoreceptors from cell death and improves functional outcome after experimental retinal detachment. Am J Pathol 2012, 181:1634-1641.
87. Degterev A., Hitomi J., Germscheid M., Ch'en I.L., Korkina O., Teng X., et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008, 4:313-321.
88. Sipieter F., Ladik M., Vandenabeele P., Riquet F. Shining light on cell death processes - a novel biosensor for necroptosis, a newly described cell death program. Biotechnol J 2014, 9:224-240.
89. Duprez L., Takahashi N., Van Hauwermeiren F., Vandendriessche B., Goossens V., Vanden Berghe T., et al. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 2011, 35:908-918.
90. Wu J., Huang Z., Ren J., Zhang Z., He P., Li Y., et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res 2013, 23:994-1006.
91. Degterev A., Huang Z., Boyce M., Li Y., Jagtap P., Mizushima N., et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005, 1:112-119.
92. Wang K., Li J., Degterev A., Hsu E., Yuan J., Yuan C. Structure-activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5. Bioorg Med Chem Lett 2007, 17:1455-1465.
93. Teng X., Keys H., Yuan J., Degterev A., Cuny G.D. Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors. Bioorg Med Chem Lett 2008, 18:3219-3223.
94. Teng X., Keys H., Jeevanandam A., Porco J.A., Degterev A., Yuan J., et al. Structure-activity relationship study of [1,2,3]thiadiazole necroptosis inhibitors. Bioorg Med Chem Lett 2007, 17:6836-6840.
95. Jagtap P.G., Degterev A., Choi S., Keys H., Yuan J., Cuny G.D. Structure-activity relationship study of tricyclic necroptosis inhibitors. J Med Chem 2007, 50:1886-1895.
96. Teng X., Degterev A., Jagtap P., Xing X., Choi S., Denu R., et al. Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett 2005, 15:5039-5044.
97. Xie T., Peng W., Liu Y., Yan C., Maki J., Degterev A., et al. Structural basis of RIP1 inhibition by necrostatins. Structure 2013, 21:493-499.
98. Harris P.A., Bandyopadhyay D., Berger S.B., Campobasso N., Capriotti C.A., Cox J.A., et al. Discovery of small molecule RIP1 kinase inhibitors for the treatment of pathologies associated with necroptosis. ACS Med Chem Lett 2013, 4:1238-1243.
99. Smith C.C., Davidson S.M., Lim S.Y., Simpkin J.C., Hothersall J.S., Yellon D.M. Necrostatin: a potentially novel cardioprotective agent. Cardiovasc Drugs Ther 2007, 21:227-233.
100. Rosenbaum D.M., Degterev A., David J., Rosenbaum P.S., Roth S., Grotta J.C., et al. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res 2010, 88:1569-1576.
101. Zhu S., Zhang Y., Bai G., Li H. Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease. Cell Death Dis 2011, 2:e115.
102. Muller A.J., DuHadaway J.B., Donover P.S., Sutanto-Ward E., Prendergast G.C. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med 2005, 11:312-319.
103. Soliman H., Mediavilla-Varela M., Antonia S. Indoleamine 2,3-dioxygenase: is it an immune suppressor. Cancer J 2010, 16:354-359.
104. Takahashi N., Duprez L., Grootjans S., Cauwels A., Nerinckx W., DuHadaway J.B., et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 2012, 3:e437.
105. Biton S., Ashkenazi A. NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-alpha feedforward signaling. Cell 2011, 145:92-103.
106. Zheng W., Degterev A., Hsu E., Yuan J., Yuan C. Structure-activity relationship study of a novel necroptosis inhibitor, necrostatin-7. Bioorg Med Chem Lett 2008, 18:4932-4935.
107. Choi S., Keys H., Staples R.J., Yuan J., Degterev A., Cuny G.D. Optimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability. Bioorg Med Chem Lett 2012, 22:5685-5688.
108. Li J.X., Feng J.M., Wang Y., Li X.H., Chen X.X., Su Y., et al. The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury. Cell Death Dis 2014, 5:e1278.
109. Chen W., Wang Q., Bai L., Wang X., Tellez C.S., Leng S., et al. RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1alpha-mediated mitochondrial oxidative phosphorylation and glycolysis. Cell Death Differ 2014, 21:1061-1070.
110. Vanlangenakker N., Vanden Berghe T., Krysko D.V., Festjens N., Vandenabeele P. Molecular mechanisms and pathophysiology of necrotic cell death. Curr Mol Med 2008, 8:207-220.
111. Halestrap A.P. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 2006, 34:232-237.
112. Lim S.Y., Davidson S.M., Mocanu M.M., Yellon D.M., Smith C.C. The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore. Cardiovasc Drugs Ther 2007, 21:467-469.
113. Xu X., Chua K.W., Chua C.C., Liu C.F., Hamdy R.C., Chua B.H. Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury. Brain Res 2010, 1355:189-194.
114. Linkermann A., Brasen J.H., Darding M., Jin M.K., Sanz A.B., Heller J.O., et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci USA 2013, 110:12024-12029.
115. Linkermann A., Brasen J.H., Himmerkus N., Liu S., Huber T.B., Kunzendorf U., et al. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 2012, 81:751-761.
116. Chavez-Valdez R., Martin L.J., Northington F.J. Programmed necrosis: a prominent mechanism of cell death following neonatal brain injury. Neurol Res Int 2012, 2012:257563.
117. Northington F.J., Chavez-Valdez R., Graham E.M., Razdan S., Gauda E.B., Martin L.J. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 2011, 31:178-189.
118. Luedde M., Lutz M., Carter N., Sosna J., Jacoby C., Vucur M., et al. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res 2014, 103:206-216.
119. Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003, 4:399-415.
120. Zhu X., Tao L., Tejima-Mandeville E., Qiu J., Park J., Garber K., et al. Plasmalemma permeability and necrotic cell death phenotypes after intracerebral hemorrhage in mice. Stroke 2012, 43:524-531.
121. Clark R.S., Nathaniel P.D., Zhang X., Dixon C.E., Alber S.M., Watkins S.C., et al. boc-Aspartyl(OMe)-fluoromethylketone attenuates mitochondrial release of cytochrome c and delays brain tissue loss after traumatic brain injury in rats. J Cereb Blood Flow Metab 2007, 27:316-326.
122. Bermpohl D., You Z., Lo E.H., Kim H.H., Whalen M.J. TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice. J Cereb Blood Flow Metab 2007, 27:1806-1818.
123. You Z., Savitz S.I., Yang J., Degterev A., Yuan J., Cuny G.D., et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 2008, 28:1564-1573.
124. King M.D., Whitaker-Lea W.A., Campbell J.M., Alleyne C.H., Dhandapani K.M. Necrostatin-1 reduces neurovascular injury after intracerebral hemorrhage. Int J Cell Biol 2014, 2014:495817.
125. Wang Y.Q., Wang L., Zhang M.Y., Wang T., Bao H.J., Liu W.L., et al. Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model. Neurochem Res 2012, 37:1849-1858.
126. Wang Y., Wang H., Tao Y., Zhang S., Wang J., Feng X. Necroptosis inhibitor necrostatin-1 promotes cell protection and physiological function in traumatic spinal cord injury. Neuroscience 2014, 266:91-101.
127. Liu M., Wu W., Li H., Li S., Huang L.T., Yang Y.Q., et al. Necroptosis, a novel type of programmed cell death, contributes to early neural cells damage after spinal cord injury in adult mice. J Spinal Cord Med 2014, [Epub ahead of print].
128. Qinli Z., Meiqing L., Xia J., Li X., Weili G., Xiuliang J., et al. Necrostatin-1 inhibits the degeneration of neural cells induced by aluminum exposure. Restor Neurol Neurosci 2013, 31:543-555.
129. Trichonas G., Murakami Y., Thanos A., Morizane Y., Kayama M., Debouck C.M., et al. Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci USA 2010, 107:21695-21700.
130. Murakami Y., Matsumoto H., Roh M., Suzuki J., Hisatomi T., Ikeda Y., et al. Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration. Proc Natl Acad Sci USA 2012, 109:14598-14603.
131. Tamura R., Nemoto T., Maruta T., Onizuka S., Yanagita T., Wada A., et al. Up-regulation of NaV1.7 sodium channels expression by tumor necrosis factor-alpha in cultured bovine adrenal chromaffin cells and rat dorsal root ganglion neurons. Anesth Analg 2014, 118:318-324.
132. Hanus J., Zhang H., Wang Z., Liu Q., Zhou Q., Wang S. Induction of necrotic cell death by oxidative stress in retinal pigment epithelial cells. Cell Death Dis 2013, 4:e965.
133. Kaiser A.M., Saluja A.K., Sengupta A., Saluja M., Steer M.L. Relationship between severity, necrosis, and apoptosis in five models of experimental acute pancreatitis. Am J Physiol 1995, 269:C1295-C1304.
134. Mareninova O.A., Sung K.F., Hong P., Lugea A., Pandol S.J., Gukovsky I., et al. Cell death in pancreatitis: caspases protect from necrotizing pancreatitis. J Biol Chem 2006, 281:3370-3381.
135. Linkermann A., Brasen J.H., De Zen F., Weinlich R., Schwendener R.A., Green D.R., et al. Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-alpha-induced shock. Mol Med 2012, 18:577-586.
136. Vandenabeele P., Grootjans S., Callewaert N., Takahashi N. Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models. Cell Death Differ 2013, 20:185-187.
137. Jouan-Lanhouet S., Arshad M.I., Piquet-Pellorce C., Martin-Chouly C., Le Moigne-Muller G., Van Herreweghe F., et al. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ 2012, 19:2003-2014.
138. Liedtke C., Bangen J.M., Freimuth J., Beraza N., Lambertz D., Cubero F.J., et al. Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. Gastroenterology 2011, 141:2176-2187.
139. Ramachandran A., McGill M.R., Xie Y., Ni H.M., Ding W.X., Jaeschke H. Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 2013, 58:2099-2108.
140. Zhang Y.F., He W., Zhang C., Liu X.J., Lu Y., Wang H., et al. Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necroptosis during acetaminophen-evoked acute liver failure in mice. Toxicol Lett 2014, 225:445-453.
141. Nagata K., Suzuki H., Sakaguchi S. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicol Sci 2007, 32:453-468.
142. Roychowdhury S., Chiang D.J., Mandal P., McMullen M.R., Liu X., Cohen J.I., et al. Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CCl4 -induced fibrosis but not steatosis or inflammation. Alcohol Clin Exp Res 2012, 36:1139-1147.
143. Roychowdhury S., McMullen M.R., Pisano S.G., Liu X., Nagy L.E. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 2013, 57:1773-1783.
144. Gautheron J., Vucur M., Reisinger F., Cardenas D.V., Roderburg C., Koppe C., et al. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol Med 2014, 6:1062-1074.
145. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
146. Bantel H., Schulze-Osthoff K. Cell death in sepsis: a matter of how, when, and where. Crit Care 2009, 13:173.
147. Welz P.S., Wullaert A., Vlantis K., Kondylis V., Fernandez-Majada V., Ermolaeva M., et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 2011, 477:330-334.
148. Bonnet M.C., Preukschat D., Welz P.S., van Loo G., Ermolaeva M.A., Bloch W., et al. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 2011, 35:572-582.
149. Kovalenko A., Kim J.C., Kang T.B., Rajput A., Bogdanov K., Dittrich-Breiholz O., et al. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J Exp Med 2009, 206:2161-2177.
150. Kinsey G.R., Okusa M.D. Pathogenesis of acute kidney injury: foundation for clinical practice. Am J Kidney Dis 2011, 58:291-301.
151. Tristao V.R., Goncalves P.F., Dalboni M.A., Batista M.C., Durao Mde S., Monte J.C. Nec-1 protects against nonapoptotic cell death in cisplatin-induced kidney injury. Ren Fail 2012, 34:373-377.
152. Linkermann A., Heller J.O., Prokai A., Weinberg J.M., De Zen F., Himmerkus N., et al. The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice. J Am Soc Nephrol 2013, 24:1545-1557.
153. Chan F.K., Shisler J., Bixby J.G., Felices M., Zheng L., Appel M., et al. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem 2003, 278:51613-51621.
154. Ruby J., Bluethmann H., Peschon J.J. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. J Exp Med 1997, 186:1591-1596.
155. Brune W., Menard C., Heesemann J., Koszinowski U.H. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 2001, 291:303-305.
156. Mack C., Sickmann A., Lembo D., Brune W. Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc Natl Acad Sci USA 2008, 105:3094-3099.
157. Upton J.W., Kaiser W.J., Mocarski E.S. Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem 2008, 283:16966-16970.
158. Shisler J.L., Moss B. Immunology 102 at poxvirus U: avoiding apoptosis. Semin Immunol 2001, 13:67-72.
159. Chaudhary P.M., Eby M., Jasmin A., Bookwalter A., Murray J., Hood L. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 1997, 7:821-830.
160. Bolton D.L., Hahn B.I., Park E.A., Lehnhoff L.L., Hornung F., Lenardo M.J. Death of CD4(+) T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis. J Virol 2002, 76:5094-5107.
161. Borthwick N.J., Wickremasinghe R.G., Lewin J., Fairbanks L.D., Bofill M. Activation-associated necrosis in human immunodeficiency virus infection. J Infect Dis 1999, 179:352-360.
162. Pan T., Wu S., He X., Luo H., Zhang Y., Fan M., et al. Necroptosis takes place in human immunodeficiency virus type-1 (HIV-1)-infected CD4+ T lymphocytes. PLoS ONE 2014, 9:e93944.
163. Peri P., Nuutila K., Vuorinen T., Saukko P., Hukkanen V. Cathepsins are involved in virus-induced cell death in ICP4 and Us3 deletion mutant herpes simplex virus type 1-infected monocytic cells. J Gen Virol 2011, 92:173-180.
164. Chu J.J., Ng M.L. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J Gen Virol 2003, 84:3305-3314.
165. Roivainen M., Rasilainen S., Ylipaasto P., Nissinen R., Ustinov J., Bouwens L., et al. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 2000, 85:432-440.
166. Saelens X., Festjens N., Parthoens E., Vanoverberghe I., Kalai M., van Kuppeveld F., et al. Protein synthesis persists during necrotic cell death. J Cell Biol 2005, 168:545-551.
167. Berger A.K., Danthi P. Reovirus activates a caspase-independent cell death pathway. MBio 2013, 4:e00178-e213.
168. Osborn S.L., Diehl G., Han S.J., Xue L., Kurd N., Hsieh K., et al. Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. Proc Natl Acad Sci USA 2010, 107:13034-13039.
169. McComb S., Cheung H.H., Korneluk R.G., Wang S., Krishnan L., Sad S. cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death Differ 2012, 19:1791-1801.
170. Robinson N., McComb S., Mulligan R., Dudani R., Krishnan L., Sad S. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat Immunol 2012, 13:954-962.
171. Roca F.J., Ramakrishnan L. TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell 2013, 153:521-534.
172. Uzal F.A., McClane B.A. Recent progress in understanding the pathogenesis of Clostridium perfringens type C infections. Vet Microbiol 2011, 153:37-43.
173. Autheman D., Wyder M., Popoff M., D'Herde K., Christen S., Posthaus H. Clostridium perfringens beta-toxin induces necrostatin-inhibitable, calpain-dependent necrosis in primary porcine endothelial cells. PLoS ONE 2013, 8:e64644.
174. Takahashi1 N., Vereecke L., Bertrand M.J.M., Duprez L., Berger S.B., Divert T., et al. RIPK1 is a guardian of intestinal homeostasis protecting the epithelium against apoptosis. Nature 2014, 10.1038/nature13706.